Raydiant Oxymetry
San Ramon, US · Founded 2016 · 12 known investors
Find your way into Raydiant Oxymetry
105 people in our graph share verified history with the Raydiant Oxymetry team — schools, employers, funds. One of them is your warm intro.
Raydiant Oximetry is developing technology to reduce complications and emergency interventions during childbirth. The company serves obstetric healthcare providers and aims to improve maternal and fetal outcomes.
Founders & leadership
Raydiant Oxymetry was founded in 2016 by Neil P. Ray.

Board
Investors · 12
How we know: the company's own site · Avestria Ventures's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: FemHealth Ventures's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us
How we know: SteelSky Ventures's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: Cross-Border Impact Ventures's portfolio page · Not right? Tell us
How we know: Foreground Capital's portfolio page · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$13.9M disclosed across 7 rounds · 2018–2024
▶$4.3MraisedJun 2024 · 32 investors · Other Health CareRule 506(b)
- Debra ReisenthelDirector
- Elizabeth BaileyDirector
- Charles McDonaldDirector
- Neil P. RayExecutive Officer, Director
- Annie TheriaultDirector
- Russ DeLonzorExecutive Officer
- Offering amount
- $5.4M
- Amount sold
- $4.3M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedJul 2021 · 13 investors · Other TechnologyRule 506(b)
- Charles McDonaldDirector
- Russ DeLonzorExecutive Officer
- John F. MaroneyDirector
- Neil P. RayExecutive Officer, Director
- Terri BurkeDirector
- Debra ReisenthelDirector
- Offering amount
- $5.1M
- Amount sold
- $2M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$50KraisedFeb 2020 · 1 investors · Other TechnologyRule 506(c)
- Neil P. RayExecutive Officer, Director
- John MaroneyDirector
- Charles McDonaldDirector
- Terri BurkeDirector
- Debra ReisenthelDirector
- Offering amount
- $770.5K
- Amount sold
- $50K
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06c
▶$900KraisedDec 2019 · 11 investors · Other TechnologyRule 506(b)
- Debra ReisenthelDirector
- Terri BurkeDirector
- Charles McDonaldDirector
- John MaroneyDirector
- Neil P. RayExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $900K
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$3.2MraisedSep 2019 · 25 investors · Other TechnologyRule 506(c)
- Neil P. RayExecutive Officer, Director
- John MaroneyDirector
- Terri BurkeDirector
- Debra ReisenthelDirector
- Charles McDonaldDirector
- Offering amount
- $3.2M
- Amount sold
- $3.2M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06c
▶$2.5MraisedMay 2019 · 38 investors · Other TechnologyRule 506(b)
- Neil P. RayExecutive Officer, Director
- John MaroneyDirector
- Charles McDonaldDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$993KraisedAug 2018 · 12 investors · Other TechnologyRule 506(b)
- John MaroneyDirector
- Charles McDonaldDirector
- Neil P. RayExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $993K
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Raydiant Oxymetry for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Raydiant Oxymetry do?
- Raydiant Oximetry is developing technology to reduce complications and emergency interventions during childbirth. The company serves obstetric healthcare providers and aims to improve maternal and fetal outcomes.
- Who founded Raydiant Oxymetry?
- Raydiant Oxymetry was founded by Neil P. Ray in 2016.
- Who are Raydiant Oxymetry's investors?
- Raydiant Oxymetry's investors include Avestria Ventures, Band of Angels, FemHealth Ventures, SteelSky Ventures, Tri-Valley Ventures, Bill & Melinda Gates Foundation, Rhia Ventures, VCapital and 4 more.
- How much funding has Raydiant Oxymetry raised?
- Raydiant Oxymetry has disclosed $13.9M raised across 7 rounds.
- Where is Raydiant Oxymetry headquartered?
- Raydiant Oxymetry is headquartered in San Ramon, US.








